These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34842295)

  • 21. Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
    Abelein A
    Acc Chem Res; 2023 Oct; 56(19):2653-2663. PubMed ID: 37733746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (Bio)chemical Strategies To Modulate Amyloid-β Self-Assembly.
    Ayala S; Genevaux P; Hureau C; Faller P
    ACS Chem Neurosci; 2019 Aug; 10(8):3366-3374. PubMed ID: 31265239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers.
    Louros N; Ramakers M; Michiels E; Konstantoulea K; Morelli C; Garcia T; Moonen N; D'Haeyer S; Goossens V; Thal DR; Audenaert D; Rousseau F; Schymkowitz J
    Nat Commun; 2022 Mar; 13(1):1351. PubMed ID: 35292653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation.
    Vitalis A; Caflisch A
    J Mol Biol; 2010 Oct; 403(1):148-165. PubMed ID: 20709081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.
    Drummond E; Kavanagh T; Pires G; Marta-Ariza M; Kanshin E; Nayak S; Faustin A; Berdah V; Ueberheide B; Wisniewski T
    Acta Neuropathol Commun; 2022 Apr; 10(1):53. PubMed ID: 35418158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation.
    Hasecke F; Niyangoda C; Borjas G; Pan J; Matthews G; Muschol M; Hoyer W
    Angew Chem Int Ed Engl; 2021 Feb; 60(6):3016-3021. PubMed ID: 33095508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
    PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation and structure of amyloid β-protein.
    Ono K; Watanabe-Nakayama T
    Neurochem Int; 2021 Dec; 151():105208. PubMed ID: 34655726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease.
    Xiao Y; Ma B; McElheny D; Parthasarathy S; Long F; Hoshi M; Nussinov R; Ishii Y
    Nat Struct Mol Biol; 2015 Jun; 22(6):499-505. PubMed ID: 25938662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the cross-interaction between hIAPP and Aβ
    Pang B; Zhuang X; Bian X; Liu S; Liu Z; Song F
    J Mass Spectrom; 2020 Oct; 55(10):e4643. PubMed ID: 32893436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.
    Ciccone L; Shi C; di Lorenzo D; Van Baelen AC; Tonali N
    Molecules; 2020 May; 25(10):. PubMed ID: 32456156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level.
    Wang Y; Westermark GT
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.